Low-frequency K103N strengthens the impact of transmitted drug resistance on virologic responses to first-line efavirenz or nevirapine-based highly active�…

AM Geretti, ZV Fox, CL Booth, CJ Smith…�- JAIDS Journal of�…, 2009 - journals.lww.com
Background: There are conflicting data on the impact of low-frequency transmitted drug-
resistant mutants on responses to first-line highly active antiretroviral therapy (HAART)�…
Save Cite Cited by 74 Related articles

Low-frequency K103N strengthens the impact of transmitted drug resistance on virologic responses to first-line efavirenz or nevirapine-based highly active�…

AM Geretti, ZV Fox, CL Booth…�- Journal of acquired�…, 2009 - pubmed.ncbi.nlm.nih.gov
Background There are conflicting data on the impact of low-frequency transmitted drug-
resistant mutants on responses to first-line highly active antiretroviral therapy (HAART)�…
Cite

[CITATION][C] Low-Frequency K103N Strengthens the Impact of Transmitted Drug Resistance on Virologic Responses to First-Line Efavirenz or Nevirapine-Based�…

AM GERETTI, ZV FOX, CL BOOTH…�- Journal of acquired�…, 2009 - pascal-francis.inist.fr
Low-Frequency K103N Strengthens the Impact of Transmitted Drug Resistance on Virologic
Responses to First-Line Efavirenz or Nevirapine-Based Highly Active Antiretroviral Therapy�…
Cite

Low-frequency K103N strengthens the impact of transmitted drug resistance on virologic responses to first-line efavirenz or nevirapine-based highly active�…

AM Geretti, ZV Fox, CL Booth, CJ Smith, AN Phillips… - 2009 - cabidigitallibrary.org
Background: There are conflicting data on the impact of low-frequency transmitted drug-
resistant mutants on responses to first-line highly active antiretroviral therapy (HAART)�…
Cite

Low-frequency K103N strengthens the impact of transmitted drug resistance on virologic responses to first-line efavirenz or nevirapine-based highly active�…

AM Geretti, ZV Fox, CL Booth, CJ Smith…�- Journal of Acquired�…, 2009 - europepmc.org
Background There are conflicting data on the impact of low-frequency transmitted drug-
resistant mutants on responses to first-line highly active antiretroviral therapy (HAART)�…
Cite

Low-Frequency K103N Strengthens the Impact of Transmitted Drug Resistance on Virologic Responses to First-Line Efavirenz or Nevirapine-Based Highly Active�…

AM Geretti, ZV Fox, CL Booth, CJ Smith…�- JAIDS Journal of�…, 2009 - journals.lww.com
Background: There are conflicting data on the impact of low-frequency transmitted drug-
resistant mutants on responses to first-line highly active antiretroviral therapy (HAART)�…
Cite

[CITATION][C] Low-Frequency K103N Strengthens the Impact of Transmitted Drug Resistance on Virologic Responses to First-Line Efavirenz or Nevirapine-Based�…

AM Geretti, ZV Fox, CL Booth, CJ Smith…�- JAIDS Journal of�…, 2009 - cir.nii.ac.jp
Low-Frequency K103N Strengthens the Impact of Transmitted Drug Resistance on Virologic
Responses to First-Line Efavirenz or Nevirapine-Based Highly Active Antiretroviral Therapy�…
Cite

[CITATION][C] Low-Frequency K103N Strengthens the Impact of Transmitted Drug Resistance on Virologic Responses to First-Line Efavirenz or Nevirapine-Based�…

AM GERETTI, ZV FOX, CL BOOTH…�- Journal of�…, 2009 - Lippincott Williams & Wilkins
Cite